Krognes Steve E.

Krognes Steve E. is listed in filings as Director at Guardant Health, Inc.. This profile follows SEC Form 4 activity through Jul 2, 2026, including sale activity. Recent filings connect the profile to Guardant Health, Inc. (GH) and Denali Therapeutics Inc. (DNLI). The current snapshot covers public activity from Jun 1, 2026 to Jul 2, 2026. Reported amounts are shown as $378.0K to $1.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.